ZA9394B - A novel human kunitz-type inhibitor and variants thereof - Google Patents

A novel human kunitz-type inhibitor and variants thereof

Info

Publication number
ZA9394B
ZA9394B ZA9394A ZA9394A ZA9394B ZA 9394 B ZA9394 B ZA 9394B ZA 9394 A ZA9394 A ZA 9394A ZA 9394 A ZA9394 A ZA 9394A ZA 9394 B ZA9394 B ZA 9394B
Authority
ZA
South Africa
Prior art keywords
phe
cys
gly
glu
asn
Prior art date
Application number
ZA9394A
Other languages
English (en)
Inventor
Fanny Norris
Kjeld Norris
Soeren Erik Bjoern
Lars Christian Petersen
Ole Hvilsted Olsen
Donald Cameron Foster
Cindy Ann Sprecher
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA9394B publication Critical patent/ZA9394B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
ZA9394A 1992-01-07 1993-01-07 A novel human kunitz-type inhibitor and variants thereof ZA9394B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK9200003 1992-01-07

Publications (1)

Publication Number Publication Date
ZA9394B true ZA9394B (en) 1993-08-10

Family

ID=8153772

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9394A ZA9394B (en) 1992-01-07 1993-01-07 A novel human kunitz-type inhibitor and variants thereof

Country Status (17)

Country Link
US (1) US5618696A (de)
EP (1) EP0621873B1 (de)
JP (1) JP3345420B2 (de)
KR (1) KR940703860A (de)
AT (1) ATE171712T1 (de)
AU (1) AU670059B2 (de)
CA (1) CA2127247A1 (de)
CZ (1) CZ164894A3 (de)
DE (1) DE69321342T2 (de)
ES (1) ES2123635T3 (de)
FI (1) FI943235A0 (de)
HU (1) HUT70291A (de)
IL (1) IL104314A0 (de)
NO (1) NO942553L (de)
NZ (1) NZ246571A (de)
WO (1) WO1993014123A1 (de)
ZA (1) ZA9394B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134087A1 (en) * 1988-09-02 2006-06-22 Dyax Corp. ITI-D1 Kunitz domain mutants as hNE inhibitors
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
US5780265A (en) * 1995-06-05 1998-07-14 Genentech, Inc. Kunitz type plasma kallikrein inhibitors
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
US6242414B1 (en) 1995-06-07 2001-06-05 Chiron Corporation Regulation of cytokine synthesis and release
DK2311432T3 (en) * 2002-06-07 2015-02-02 Dyax Corp Modified Kunitz domain polypeptides and their use in reducing ischemia or the onset of a systemic inflammatory response associated with a surgical procedure
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
US20040209243A1 (en) * 2003-01-07 2004-10-21 Andrew Nixon Kunitz domain library
BRPI0513267A (pt) * 2004-07-13 2008-05-06 Bayer Pharmaceuticals Corp variantes melhoradas de aprotinina
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
DK1981519T3 (en) 2005-12-29 2018-02-19 Dyax Corp protease inhibition
WO2009026334A2 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
CN101952309A (zh) * 2007-12-21 2011-01-19 Ifxa有限公司 蛋白酶抑制剂
BRPI0922344A2 (pt) 2008-12-19 2017-10-24 3B Pharmaceuticals Gmbh inibidores de tfpi e métodos de uso
US8637454B2 (en) * 2009-01-06 2014-01-28 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
ES2905545T3 (es) 2010-01-06 2022-04-11 Takeda Pharmaceuticals Co Proteínas de unión a calicreína plasmática
ES2983470T3 (es) 2010-03-19 2024-10-23 Takeda Pharmaceuticals Co Inhibidores del TFPI y métodos de uso
KR102502293B1 (ko) 2011-01-06 2023-02-21 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 결합 단백질
JP2015514070A (ja) 2012-03-21 2015-05-18 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｔｆｐｉ阻害剤および使用方法
CA2942713A1 (en) 2014-03-27 2015-10-01 Dyax Corp. Compositions and methods for treatment of diabetic macular edema
EA201891388A1 (ru) 2015-12-11 2018-11-30 Дайэкс Корп. Ингибиторы калликреина плазмы и их применение для лечения обострения наследственного ангионевротического отека
CN114807152A (zh) * 2016-06-08 2022-07-29 哈佛学院院长及董事 工程化病毒载体减少了炎症和免疫反应的诱导
EP3707262A1 (de) 2017-11-08 2020-09-16 President and Fellows of Harvard College Zusammensetzungen und verfahren zur hemmung von virusvektorinduzierten entzündungsreaktionen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
DE3724570A1 (de) * 1987-06-27 1989-01-05 Bayer Ag Human-aprotinin, dessen lys-rest in position 15 gegen einen anderen protogenen aminosaeurerest ausgetauscht ist
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor
US5106833A (en) * 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
JPH07102137B2 (ja) * 1988-07-19 1995-11-08 塩野義製薬株式会社 修飾ヒトｐｓｔｉ

Also Published As

Publication number Publication date
WO1993014123A1 (en) 1993-07-22
NZ246571A (en) 1996-09-25
FI943235A (fi) 1994-07-06
JP3345420B2 (ja) 2002-11-18
EP0621873B1 (de) 1998-09-30
DE69321342D1 (de) 1998-11-05
CA2127247A1 (en) 1993-07-22
IL104314A0 (en) 1993-05-13
HUT70291A (en) 1995-09-28
US5618696A (en) 1997-04-08
JPH07504652A (ja) 1995-05-25
NO942553L (no) 1994-09-07
ES2123635T3 (es) 1999-01-16
FI943235A0 (fi) 1994-07-06
EP0621873A1 (de) 1994-11-02
AU670059B2 (en) 1996-07-04
HU9401989D0 (en) 1994-09-28
AU3346193A (en) 1993-08-03
KR940703860A (ko) 1994-12-12
DE69321342T2 (de) 1999-04-01
CZ164894A3 (en) 1994-12-15
NO942553D0 (no) 1994-07-06
ATE171712T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
HU9401989D0 (en) A novel human kunitz-type protease inhibitor and variants thereof
HK1154211A1 (zh) 預防和減少失血和炎症反應
CA2050300A1 (en) Tnf-inhibiting proteins and the preparation thereof
MD1652F2 (en) Protein possessing the cytokin - type activity, recombinant DNA-codifyer for such protein, transformed cells and microorganism, expression vector, process for protein obtaining and remedy containing such a protein
DE69128664D1 (de) CNP-Gen und Vorläuferprotein aus Schwein
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
YU29596A (sh) Genski proizvodi koji regulišu gojaznost
CA2002924A1 (en) Anti-Thrombins
NZ334714A (en) Liver proteins as agents against autoimmune diseases
CA2077590A1 (en) Recombinant dna coding for a protein with endochitinase activity
EP0258203A3 (en) Novel substrate peptides
AU8302791A (en) Recombinant gene coding for a protein having an endochitinase activity
WO1999057262A3 (de) An metallionen bindendes peptid
EP1225184A4 (de) Menschliche antithrombin-varianten
RU94036002A (ru) Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция
PT100299A (pt) Analogo de hirudina, metodo para a sua producao e anti-coagulante contendo-o, e vector de secrecao , microorganismos transformados com o referido vector e metodo para a producao de produtos a partir dos referidos microorganismos